Jump to main content
Jump to site search

Issue 12, 2016
Previous Article Next Article

Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors

Author affiliations

Abstract

A novel series of thiadiazole derivatives were designed and synthesized for evaluation as selective COX-2 inhibitors in vitro and were investigated in vivo as anti-inflammatory and analgesic agents against carrageenan-induced rat paw oedema model in irradiated rats, since it is well-known that ionizing radiation plays an important role in exaggerating the inflammatory responses in experimental animals. Ulcerogenic activity and acute toxicity were evaluated for the most potent compounds. In order to understand the binding mode of the synthesized compounds into the active site of the COX-2 enzyme, a docking study was performed. Most of the tested compounds showed high inhibitory ability against COX-2. Among them, thiadiazole derivatives bearing sulfonamide moieties, 7b, c and 13c, e, were the most potent COX-2 inhibitors, with extremely high selectivity indices (SI) compared to celecoxib; they showed high safety margins on gastric mucosa with no ulceration effects, and they were found to be non-toxic in experimental rats. The docking study showed a similar orientation of these compounds to that of celecoxib within the active site of the COX-2 enzyme, and a similar ability to immerge deeply into the additional pocket and bind with Arg513 and His90, the key amino acids responsible for selectivity.

Graphical abstract: Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 01 Jul 2016, accepted on 05 Sep 2016 and first published on 09 Sep 2016


Article type: Research Article
DOI: 10.1039/C6MD00367B
Citation: Med. Chem. Commun., 2016,7, 2309-2327
  •   Request permissions

    Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors

    F. A. Ragab, H. I. Heiba, M. G. El-Gazzar, S. M. Abou-Seri, W. A. El-Sabbagh and R. M. El-Hazek, Med. Chem. Commun., 2016, 7, 2309
    DOI: 10.1039/C6MD00367B

Search articles by author

Spotlight

Advertisements